Versiro develops software that accelerates the energy transition. Renewable electricity is great for the environment but difficult to plan because its production depends on uncertain weather conditions. Versiro develops an AI copilot that helps renewable producers make smart decisions in real time while considering these uncertainties. This assists the integration of renewable energy and increases its profitability, two key factors to enable the green energy transition. Versiro was founded by researchers at the Norwegian University of Science and Technology (NTNU) and follows the observation that, in electric power systems, the traditional pipelines from research to industry are too outdated to keep up with the fast-paced world of machine learning.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

BusinessClass.com is a sophisticated travel tech startup. Our vision is to become the global leader in premium travel by offering the best travel search, the best travel offers, as well as world-class reviews and other inspirational content. BusinessClass.com is targeting the more quality-minded travellers who want the best travel products at the best possible prices. BusinessClass.com is suitable for both corporate & leisure travel, offering top-quality airline tickets and accommodation. The team and advisers at BusinessClass.com have extensive travel tech industry knowledge. Founder Jason Eckhoff was EY Entrepreneur Of The Year in 2013 when his first online travel company had beaten 28.000 growth companies over a 4-year period. BusinessClass.com is (other than the founder/CEO) backed by a former C-level manager of a major airline and a co-founder of a unicorn (a company valued at more than 1 USD billion). We are currently considering raising additional risk capital for further developing BusinessClass.com and creating the world's best search engine for premium travel!

Five seasoned experts with over 175 years of experience in the oil & gas industry have developed a new patent pending disruptive revolutionary technology.   Water is separated in a horizontal well bore close to the reservoir and thereafter re-injected via a lateral well as pressure support to increase oil recovery. The Fluidsep DPP combines production and injection in one well with no spill to the surface, all excess water and sand is re-injected and never sees the surfaceThe technology enables  35% extra oil production and at the same time results in significantly reduced CO2/barrel of Oil. More than a 30% reduction compared with conventional production. An example of simulations shows extra income of > 1 Billion NOK per well. Fluidsep DPP has achieved TRL 2 - and requires 2 years of qualifications and pilot testing to be ready for the market, TRL 7. Strong interest in the market about our technology. Currently inviting investors and Seed capital funds to participate in the joint development of building a new international downhole service provider based in the Bergen region.

David Strømman Nedal (born 1 march 1986) is a Norwegian fashion designer. He is the head of the Norwegian luxury suit brand Julius Caesar. Julius Caesar is a luxury private suit label that specializes in high-net customers with limited time and high demands. David is often used in the national press, both TV and print giving his advice on how to dress.

MER er et norsk musikkselskap og artistrepresentant. Vår visjon er å bli bransjens beste på å kvalitetssikre, utvikle, fasiliteter og forvalte alle aspekter ved våre klienters karriere og virke. Selskapet har kompetanse og relevant erfaring i å tilby tjenester som management, promo, merkevarebygging og labefunksjoner. MER har de siste årene blitt et internasjonalt selskap med aktivitet over hele verden. Vår største klient, Alan Walker er i dag en av verdens største EDM-artister hvilket gir store muligheter for å bli kjent med en digital musikkverden.

Lawbotics has developed an innovative tool called LEXOLVE to streamline parts of the legal processes that take place in all companies – namely the creation of legal contracts and other documents. By letting legal experts automate their own legal documents using our software, we make it easy for businesses to increase the quality of their legal documents while saving a significant amount of time and resources.

NORWEGIAN ENERGY DRINK I am challenging the unhealthy red bull drink with a healthy Norwegian energy drink, a special formula that gives you more energy and a better life, POWER TO THE PEOPLE, do you want to know more or order a case, or perhaps partner in? Call me at + 47 9216 3985 or mads@fjordvisjon.com or follow the Norwegian Energy drink

BAD NORWEGIAN is a natural skincare brand from Norway, founded by a former NATO soldier, to offer men simple products and routines. We combine the values associated with Norway: integrity, honesty, and quality- with a rogue, confident undertone. Our skincare, beard and shave products are all cruelty-free and vegan, with an instant effect. BAD NORWEGIAN is a direct-to-consumer company with a strong foothold in the travel retail market in Norway. Selling at Heinemann, BEAST, Marionnaud and Cult Beauty.

Inspired by the sharing economy we're disrupting an old-fashioned industry, saving institutions in the health care sector immense amounts of money and time.uWork is Norway's 1st platform for on-demand healthcare staffing. Launched in May 2016, uWork has already partnered up with more than 50 healthcare institutions in souther Norway, and we're expanding rapidly. Our talent pool of pre-screened healthcare specialists now consists of more than 150 uWorkers, with more signing up every single day.

NORIGIN MEDIA is a TV Everywhere company, which enables multi-screen and OTT services for carriers, broadcasters, and content owners. The Scandinavian company offers a complete multi-screen application suite and a Live TV hosting headend capacity as primary products. NORIGIN MEDIA is reinventing how people watch TV. Join the technical revolution on how people will consume TV content in the years to come. You will architect and develop user experiences that will reach millions of TV users on Smartphones, Tablets, PCs, Connected TV, and Game Consoles.

Omnidocs is a consulting and software company – but more than anything we are a document company. We create value for our customers by helping them improve their use of Microsoft Office, creating and implementing on-brand solutions that fuel productivity, embed compliance, and increase job happiness. We have a wide range of competencies when it comes to documents in a work context, but our purpose is very straightforward: We make every workday work better.

Refyne så dagens lys i efteråret 2020 og er siden blevet et af de mest respekterede og seniortunge bureauer i Danmark med mere end 20+ ansatte Vi arbejder med skræddersyede og databaserede strategier inde for SEO, Paid Search & Social, Tracking, Webanalyse og Konverteringsoptimering. Vores målsætning er at være det mest kompetente bureau, ikke det største bureau. Det er vi gennem vores nytænkende løsninger og ved at levere forretningsmæssige resultater for vores kunder. Vi arbejder både med scale-ups og markedsledende virksomheder.